These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8538293)

  • 1. [Possible effect of administration methods on pharmacological action. Study of cytostatic therapy in advanced cancer].
    Larsson PA; Carlsson G; Gustavsson B; Glimelius B; Graf W
    Lakartidningen; 1995 Dec; 92(50):4793-6. PubMed ID: 8538293
    [No Abstract]   [Full Text] [Related]  

  • 2. Systemic therapy of colorectal cancer.
    Hansen RM
    Wis Med J; 1988 May; 87(5):27-9. PubMed ID: 3291406
    [No Abstract]   [Full Text] [Related]  

  • 3. Sequential 5-fluorouracil, methotrexate, and calcium leucovorin in metastatic colorectal cancer.
    Hansen RM; Banerjee TK; Davis HL; Zaentz SD; Schiferl EA; Ousley JL; Pogodzinski AE; Trump DL
    Wis Med J; 1988 May; 87(5):20-3. PubMed ID: 3291405
    [No Abstract]   [Full Text] [Related]  

  • 4. Overview of current status and future direction of clinical trials with 5-fluorouracil in combination with folinic acid.
    Grem JL; Hoth DF; Hamilton JM; King SA; Leyland-Jones B
    Cancer Treat Rep; 1987 Dec; 71(12):1249-64. PubMed ID: 3319136
    [No Abstract]   [Full Text] [Related]  

  • 5. Chronomodulated infusion of cisplatin, 5-fluorouracil and folinic acid: lack of activity in advanced colorectal cancer.
    Natoli C; Scognamiglio MT; Martino MT; Irtelli L; De Tursi M; Cianchetti E; Mascitelli E; Tinari N; Iacobelli S
    Anticancer Res; 2000; 20(2B):1253-6. PubMed ID: 10810430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic cytostatic drug therapy in liver cancer.
    Glimelius B
    Ann Chir Gynaecol Suppl; 1986; 200():69-73. PubMed ID: 3014989
    [No Abstract]   [Full Text] [Related]  

  • 7. Schedule-selective biochemical modulation of 5-fluorouracil: a phase II study in advanced colorectal cancer.
    Sobrero AF; Aschele C; Guglielmi AP; Mori AM; Tixi LM; Bolli EA; Rosso R; Mammoliti S; Rollandi GA; Bertoglio S
    Clin Cancer Res; 1995 Sep; 1(9):955-60. PubMed ID: 9816066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of advanced colonic and rectal adenocarcinoma: combination of 5-FU and high-dose folinic acid].
    Rougier P; Droz JP; Ducreux M; Kac J; Spielmann M; Crespon B; Ley G; Zimmermann P; Theodore C; Chavy A
    Bull Cancer; 1983; 70(5):434-6. PubMed ID: 6607759
    [No Abstract]   [Full Text] [Related]  

  • 9. Double modulation with methotrexate and L-leucovorin of weekly 24- hour fluorouracil infusion in fluorouracil-refractory colorectal cancer.
    Colleoni M; Nelli P; Vicario G; Pancheri F; Sgarbossa G; Manente P
    Anticancer Res; 1996; 16(5B):3101-4. PubMed ID: 8920775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II study of sequential methotrexate and 5-FU combination in the treatment of advanced colorectal cancer.
    Canobbio L; Nobile MT; Ardizzoni A; Tatarek R; Rosso R
    Cancer Treat Rep; 1986 Mar; 70(3):419-20. PubMed ID: 3955557
    [No Abstract]   [Full Text] [Related]  

  • 11. [A clinical study of hepatic arterial infusion chemotherapy with 5-FU and leucovorin for liver metastases].
    Ichihara T; Tenma K; Itoh M; Hibino M; Kikuchi I; Sasaki Y; Hosono Y; Nakamura M
    Gan To Kagaku Ryoho; 2003 Aug; 30(8):1143-5. PubMed ID: 12938270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase II study of weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin (HDFL) in the treatment of recurrent or metastatic colorectal cancers.
    Yeh KH; Cheng AL; Lin MT; Hong RL; Hsu CH; Lin JF; Chang KJ; Lee PH; Chen YC
    Anticancer Res; 1997; 17(5B):3867-71. PubMed ID: 9427794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Puzzles in the clinical pharmacokinetics of fluorouracil.
    Desoize B; Bouche O; Berthiot G; Coninx P
    Anticancer Res; 1998; 18(6B):4607-10. PubMed ID: 9891526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequential methotrexate and 5-FU in the treatment of colorectal cancer.
    Weinerman B; Schacter B; Schipper H; Bowman D; Levitt M
    Cancer Treat Rep; 1982 Jul; 66(7):1553-5. PubMed ID: 6980048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-Fluorouracil and cytarabine--ineffective treatment in advanced colorectal carcinoma: a Southeastern Cancer Study Group Trial.
    Eisenstaedt RS; Neilan BA; Bartolucci A
    Cancer Treat Rep; 1987; 71(7-8):779-80. PubMed ID: 3300971
    [No Abstract]   [Full Text] [Related]  

  • 16. A phase II study of weekly methotrexate, cisplatin, and 24-hour infusion of high-dose 5-fluorouracil and leucovorin (MP-HDFL) in patients with metastatic and recurrent esophageal cancer-improving toxicity profile by infusional schedule and double biochemical modulation of 5-fluorouracil.
    Hsu CH; Cheng AL; Hsu C; Yang CH; Lu YS; Lin CC; Bu CF; Yeh KH
    Anticancer Res; 2002; 22(6B):3621-7. PubMed ID: 12552966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Importance of 5-fluorouracil dose-intensity in a double randomised trial on adjuvant portal and systemic chemotherapy for Dukes B2 and C colorectal cancer.
    Focan C; Bury J; Beauduin M; Herman ML; Vindevoghel A; Lecomte M; Brohée D; Canon JL; Focan-Henrard D;
    Anticancer Res; 2000; 20(6C):4665-72. PubMed ID: 11205198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant therapy of colorectal cancer.
    Kemeny N; Saltz L; Cohen A
    Surg Oncol Clin N Am; 1997 Oct; 6(4):699-722. PubMed ID: 9309089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment with cytostatic agents should be considered in colorectal cancer. It improves prognosis and quality of life].
    Larsson PA
    Lakartidningen; 1999 May; 96(19):2314-6. PubMed ID: 10377671
    [No Abstract]   [Full Text] [Related]  

  • 20. [Retrospective analysis on efficacy and toxicity of 5-fluorouracil (5-FU) and l-leucovorin (l-LV) in advanced or recurrent colorectal cancer].
    Chiba N; Yoshioka T; Kato S; Takahashi S; Shibata H; Kato S; Sakayori M; Otsuka K; Kakudo Y; Ohori H; Yamaura G; Takahashi M; Yasuda K; Ishioka C
    Gan To Kagaku Ryoho; 2005 Jul; 32(7):991-5. PubMed ID: 16044961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.